IPSC Century Therapeutics, Inc.
$1.48▲ +2.07%
Healthcare
Other
Volume 448.6K
Avg Volume (10D) 1.05M
Key Metrics & Fundamentals
Market Cap
$267.99M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.44 - 3.04
% vs 50 MA
-18.11%
% vs 200 MA
-31.10%
RSI-14
43.0
MACD Histogram
+0.0200
Beta (1Y vs SPY)
2.08
Free Cash Flow
-$20.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.62M
COGS
–
Operating Exp
$25.38M
Operating Income
-$25.38M
EBIT
-$25.38M
Pretax Income
-$34.55M
Net Income
-$34.55M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
GlobeNewswire · Oct 14, 2026 8:05 AM ET
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
GlobeNewswire · Oct 2, 2026 8:05 AM ET
Century Therapeutics Appoints Joseph Truitt to Board of Directors
GlobeNewswire · Sep 9, 2026 4:05 PM ET
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire · Aug 12, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2025
See IPSC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.